Quantcast

Latest cell therapy Stories

2014-04-08 12:30:51

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fv78n3/cardiovascular) has announced the addition of a new report "Cardiovascular Drug Delivery - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/fv78n3/cardiovascular ] to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery to the cardiovascular system is different from...

2014-04-08 08:32:20

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/492nrm/gene_therapy) has announced the addition of a new report "Gene Therapy - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/492nrm/gene_therapy ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Gene therapy can be broadly defined as the transfer of defined genetic material to specific target...

2014-04-08 08:30:44

ST. LOUIS, April 8, 2014 /PRNewswire/ -- ISTO Technologies, Inc. ("ISTO," the "Company"), a privately-held regenerative medicine company applying its proprietary platform technologies to orthopedic and spine applications, has appointed Phillip W. Kuhn, a medical technology executive with over three decades of industry experience, as the Company's Chief Commercial Officer. In this newly created role, Mr. Kuhn will oversee ISTO's commercial strategy, including the execution of...

2014-04-07 08:32:26

Will Also Present Update on Ongoing Phase II Trial ROCKVILLE, Md., April 7, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, PhD, MD, principal investigator of Neuralstem's NSI-566 stem cell trial in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) will present Phase I data at the Keystone Symposia, "Engineering Cell Fate and Function," in Olympic Valley, California, on April 9(th...

2014-04-07 08:32:15

Members committed to the standardization of cell therapies, regenerative medicine drugs and other biologics. LARKSPUR, Calif., April 7, 2014 /PRNewswire/ -- Today BioCision, LLC, a leader in advanced temperature management technologies that standardize biomaterial handling, announced the establishment of the company's first advisory board. Lori Kunkel, MD, former chief medical officer at Pharmacyclics, Inc., will serve as chair of the board, and will be joined by Scott Burger, MD,...

2014-04-04 23:41:39

Dr. Jeffrey Adler of Adler Footcare New York will discuss stem cell replacement therapy, a new treatment option available to treat painful foot problems, on NewsTalkRadio 77 WABC in New York City on April 5. New York, New York (PRWEB) April 03, 2014 Dr. Jeffrey Adler, New York podiatrist and Owner/Medical Director of Adler Footcare New York, will be interviewed by radio personality Laura Smith and taking live calls on New York talk show 77 WABC about the use of stem cells to treat...

2014-04-02 08:32:13

Autologous Cells Modified with Licensed T Cell Receptor (TCR) IP from University of Pennsylvania Studied for Safety, Bioactivity, and Effectiveness to Treat Multiple Myeloma BOTHELL, Wash., April 2, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced that Oxford, UK...

2014-04-01 20:21:51

DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/7vkq8r/global_stem_cell) has announced the addition of the "Global Stem Cell Umbilical Cord Blood (UCB) Market - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast to 2020" [http://www.researchandmarkets.com/research/7vkq8r/global_stem_cell ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...

Big Breakthrough In Stem Cell Manufacturing Technology
2014-04-01 13:07:09

University of Nottingham Scientists at The University of Nottingham have developed a new substance which could simplify the manufacture of cell therapy in the pioneering world of regenerative medicine. Cell therapy is an exciting and rapidly developing area of medicine in which stem cells have the potential to repair human tissue and maintain organ function in chronic disease and age-related illnesses. But a major problem with translating current successful research into actual products...

2014-04-01 08:30:20

Safety, Efficacy, Patient Satisfaction Drive StemGenex' Efforts toward Best-in-Class Stem Cell Treatment LA JOLLA, Calif., April 1, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today reinforced their commitment to attaining the highest treatment standards in the U.S. StemGenex believes by focusing on three key areas of treatment, patients will continue...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related